KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Invested Capital (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Invested Capital for 17 consecutive years, with $65.7 billion as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 6.33% to $65.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.7 billion through Dec 2025, up 6.33% year-over-year, with the annual reading at $65.7 billion for FY2025, 6.33% up from the prior year.
  • Invested Capital hit $65.7 billion in Q4 2025 for Abbott Laboratories, up from $63.9 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $65.7 billion in Q4 2025 to a low of -$8.3 billion in Q2 2022.
  • Historically, Invested Capital has averaged $19.3 billion across 5 years, with a median of $11.4 billion in 2022.
  • Biggest five-year swings in Invested Capital: plummeted 1175.29% in 2022 and later surged 2154.34% in 2023.
  • Year by year, Invested Capital stood at $18.3 billion in 2021, then plummeted by 52.27% to $8.7 billion in 2022, then decreased by 21.58% to $6.8 billion in 2023, then skyrocketed by 803.35% to $61.8 billion in 2024, then rose by 6.33% to $65.7 billion in 2025.
  • Business Quant data shows Invested Capital for ABT at $65.7 billion in Q4 2025, $63.9 billion in Q3 2025, and $6.9 billion in Q2 2025.